The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bayer Schering Pharma; Ipsen; Merck Serono; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; Ipsen; Merck Serono; Roche/Genentech
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer Schering Pharma; Ipsen; Merck Serono; MSD Oncology; Roche/Genentech
Postoperative hepatic arterial chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: A multicenter randomized phase II trial (PRODIGE 43 - PACHA-01).
 
Maximiliano Gelli
No Relationships to Disclose
 
Jacques Ewald
No Relationships to Disclose
 
Marie Laure Tanguy
No Relationships to Disclose
 
Guillaume Passot
No Relationships to Disclose
 
Francois Quenet
Honoraria - Ethicon; Gamida Cell; Sanofi Aventis GmbH
Consulting or Advisory Role - Gamida Cell
Travel, Accommodations, Expenses - Ethicon/Johnson & Johnson; Gamida Cell
 
Yann Touchefeu
Consulting or Advisory Role - BMS GmbH & Co. KG; Merck Serono; Pierre Fabre; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
 
Hélène Senellart
No Relationships to Disclose
 
Fabrice Muscari
No Relationships to Disclose
 
Astrid Lievre
Honoraria - Advanced Accelerator Applications; Amgen; Bayer; Bristol-Myers Squibb (Mexico); Incyte; Ipsen; LEO Pharma; Mylan; Novartis; Pierre Fabre; Roche; SERVIER; Viatris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bristol-Myers Squibb (Mexico); Incyte; Pierre Fabre; SERVIER
Research Funding - Bayer (Inst); IntegraGen (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen; MSD Oncology; Mylan; Pierre Fabre; Roche; SERVIER
 
René Adam
Honoraria - Merck; Sanofi
 
Thomas Aparicio
Honoraria - Amgen; Pierre Fabre; Servier
Consulting or Advisory Role - Bristol Myers Squibb; Bristol Myers Squibb; MSD Oncology; Pierre Fabre; Sirtex Medical
Travel, Accommodations, Expenses - MSD Oncology; Pierre fabre
 
Julien Taieb
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Merck KGaA; MSD; Novartis; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Charles Mastier
No Relationships to Disclose
 
jean-Marc Regimbeau
No Relationships to Disclose
 
Amani Asnacios Lecerf
No Relationships to Disclose
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Sanofi
 
Valerie Boige
No Relationships to Disclose
 
Thierry De Baere
No Relationships to Disclose
 
David Malka
Honoraria - Amgen; AstraZeneca; Bayer; Bristol Myers Squibb; Foundation Medicine; Incyte; LEO Pharma; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Sanofi; SERVIER; Veracyte; Viatris
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bionest partners; Bionest partners; Bristol Myers Squib; Incyte; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Simon-Kucher and Partners; Taiho Oncology
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb/Pfizer; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier; Viatris
 
Diane Goere
No Relationships to Disclose